Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CaliberRx vs JRNYS

CaliberRx
Graded #370

Lower grade

vs+13.200000000000003
JRNYS
Graded #88

Higher grade

The verdict

JRNYS takes it — 71.7/100 to 58.5/100.

JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss program built around branded GLP-1 medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), dulaglutide, and liraglutide (Saxenda), paired…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJRNYS +33
45
78
Dose & formulationJRNYS +30
40
70
Clinical oversightCaliberRx +4
88
84
Labs & monitoringJRNYS +6
55
61
FulfillmentCaliberRx +10
75
65
Contract termsEven
55
55
CaliberRx · left barJRNYS · right bar

The numbers

MetricCaliberRxJRNYS
WeighScore58.5/10071.7/100
GradeCC
Scorecard rank#370#88
SemaglutideNot disclosed$89/mo (plus a separate fee, brand-name)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
CaliberRx

Graded #370 · C

Strengths

  • Compounded GLP-1 — semaglutide and tirzepatide — prescribed by licensed clinicians after an online medical-history review
  • 100% online with free, discreet delivery and 24/7 medical support; no insurance required
  • Unusually thorough legal/compliance suite (privacy practices, telehealth consent, state-privacy addendum, refund, billing, program disclaimers)
  • Personalized plan written by a licensed provider based on your individualized assessment

Where it loses points

  • Pricing is not published — it is shown only after you complete the intake quiz
  • Compounded GLP-1s are not FDA-approved, and the compounding pharmacy is not named
  • State-availability list is not published
  • No LegitScript certification displayed
JRNYS

Graded #88 · C

Strengths

  • Branded GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda)
  • Insured members may pay ~$25/mo for medication after deductible
  • Includes 1-on-1 coaching at every membership tier
  • Led by CMO Dr. Henry Legere with strong academic credentials
  • Transparent membership pricing ($89-$169/mo)

Where it loses points

  • Medication cost separate from membership; self-pay varies
  • Best value requires commercial insurance coverage
  • Compounded option not disclosed; brand-focused
  • State availability not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard